Galderma Global Survey Reveals Rising Demand for Long-Lasting, Natural-Looking Anti-Wrinkle Treatments
Galderma has unveiled the results of a major international survey examining the expectations, preferences, and experiences of both patients and healthcare professionals (HCPs) regarding anti-wrinkle aesthetic treatments. Conducted across the United States, Brazil, the United Kingdom, and China, the study is one of the largest surveys ever undertaken in the field of aesthetic medicine and provides valuable insights into how the rapidly growing anti-wrinkle treatment market is evolving.
The findings highlight a strong and growing demand for treatments that deliver long-lasting, natural-looking results while also providing visible improvements quickly. The survey further demonstrates the increasing importance of clinical evidence, product performance, and treatment convenience in influencing both patient satisfaction and healthcare professional decision-making.
As a global leader in dermatology and aesthetic medicine, Galderma views the survey as part of its broader commitment to advancing scientific understanding of patient needs and supporting innovation in aesthetic treatments. The results offer a detailed picture of the factors shaping the future of anti-wrinkle injectables, one of the most widely performed nonsurgical cosmetic procedures worldwide.
Growing Popularity of Anti-Wrinkle Treatments
Anti-wrinkle injectables have become a cornerstone of aesthetic medicine over the past two decades. Their popularity continues to grow as more people seek minimally invasive cosmetic procedures that can enhance appearance without the need for surgery.
According to the survey, interest in these treatments remains exceptionally strong. Globally, 85% of respondents indicated that they intend to maintain or increase their use of anti-wrinkle treatments in the future. The enthusiasm was particularly notable in China, where 97% of surveyed patients expressed plans to continue or expand their use of such procedures. In the United Kingdom, the figure reached 87%.
These findings suggest that demand for anti-wrinkle injectables is likely to continue rising in the years ahead, creating opportunities for innovation while also increasing expectations regarding treatment outcomes.
As more patients enter the aesthetic market and existing users continue their treatment journeys, healthcare providers and manufacturers face growing pressure to deliver solutions that align with evolving consumer preferences.
Healthcare Professionals Prioritize Product Performance
One of the most significant findings of the survey is the emphasis healthcare professionals place on treatment performance when evaluating anti-wrinkle products.
The study included dermatologists, plastic surgeons, aesthetic physicians, and nurse injectors, all of whom regularly perform cosmetic injectable procedures. Their responses revealed a clear preference for products that provide consistent, clinically proven outcomes.
When asked which features would most influence their decision to purchase an anti-wrinkle injectable, nearly three-quarters of respondents identified long-lasting results of at least six months as one of their top priorities.
Highly active and pure formulations also ranked among the most important considerations, reflecting the desire for products that can deliver reliable efficacy while maintaining strong safety profiles.
Fast onset of action emerged as another major factor. Many healthcare professionals indicated that treatments capable of producing visible effects as early as the first day after injection were highly desirable.
The same trends appeared when practitioners were asked what factors would motivate them to switch from an existing product to a new one. Long-lasting effectiveness, formulation quality, and rapid visible results remained the most influential characteristics.
These findings underscore the increasing importance of performance-based differentiation within the aesthetic market, where healthcare providers are looking for solutions that help maximize patient satisfaction while minimizing the need for frequent retreatment.
Clinical Evidence Remains Essential
Beyond product performance, healthcare professionals also demonstrated a strong preference for therapies supported by rigorous scientific research.
Reliable clinical outcomes were identified as one of the most important factors influencing treatment selection. Practitioners emphasized the value of predictable and reproducible results when choosing products for their patients.
Robust clinical studies also ranked among the top considerations. The survey suggests that healthcare providers continue to place significant trust in evidence-based medicine and rely heavily on clinical data when evaluating new aesthetic products.
Natural-looking outcomes were another major priority. While patients increasingly seek cosmetic improvements, many prefer subtle enhancements that preserve facial expression and avoid an overly treated appearance.
The preference for natural aesthetics was consistently reflected across healthcare professional responses, indicating that future innovation in anti-wrinkle treatments will likely focus not only on effectiveness but also on delivering results that appear authentic and individualized.
Convenience and Workflow Efficiency Gain Importance
The survey also revealed a growing interest in treatment convenience and operational efficiency.
Healthcare professionals indicated that ease of use has become an increasingly valuable attribute in aesthetic products. Features such as streamlined preparation processes, simplified administration, and ready-to-use liquid formulations were viewed positively.
As aesthetic practices become busier and patient demand continues to rise, products that improve workflow efficiency may offer significant advantages.
Reducing preparation time can help practitioners manage higher patient volumes while maintaining treatment quality and consistency. This trend reflects broader changes across healthcare, where efficiency and convenience are becoming important factors in technology adoption.
Patients Value Long-Lasting Results
While healthcare professionals focus on clinical performance and scientific evidence, patients are primarily concerned with the visible and personal benefits of treatment.
One of the strongest themes emerging from the survey was the importance of long-lasting results. A large majority of patients indicated that they would be willing to pay more for treatments capable of maintaining effectiveness for six months or longer.
This preference aligns closely with actual treatment patterns observed among respondents. More than 70% reported receiving anti-wrinkle injections only once or twice each year, suggesting that durability is highly valued because it reduces the need for frequent appointments and repeated procedures.
For many patients, longer-lasting outcomes translate into greater convenience, lower overall treatment burden, and improved satisfaction.
The desire for durable results mirrors trends seen across the broader healthcare and consumer markets, where individuals increasingly seek solutions that combine effectiveness with convenience.
Demand for Faster Visible Improvements
Patients also expressed strong interest in treatments that provide rapid visible improvements.
The prospect of seeing noticeable changes as early as the first day after treatment received particularly high ratings among survey participants.
Quick results are especially appealing in aesthetic medicine because they allow individuals to experience the benefits of treatment sooner, often enhancing confidence and satisfaction shortly after the procedure.
This finding suggests that future product development may increasingly focus on balancing long-term durability with rapid onset of action.
For manufacturers, achieving both objectives simultaneously represents an important opportunity for innovation and differentiation.
Emotional Benefits Drive Patient Satisfaction
Perhaps the most compelling insight from the survey relates to the emotional impact of anti-wrinkle treatments.
When asked about the benefits they experience after treatment, patients most frequently cited increased confidence, improved appearance, and enhanced overall well-being.
These responses highlight the broader role aesthetic procedures can play in supporting self-image and quality of life. For many individuals, anti-wrinkle treatments are not solely about reducing visible signs of aging but also about feeling more comfortable and confident in social and professional settings.
Natural-looking results ranked among the most highly valued outcomes, reinforcing the growing preference for subtle enhancements that preserve individuality while improving appearance.
Reliable results and long-lasting effectiveness were also identified as major contributors to patient satisfaction, demonstrating significant alignment between patient expectations and healthcare professional priorities.
Insights from a Diverse Global Audience
The survey engaged 280 patients and 162 healthcare professionals across four major international markets.
Patient participants either had received anti-wrinkle injectable treatments within the previous 12 months or planned to undergo treatment within the next three months. The healthcare professional group included specialists from multiple disciplines involved in aesthetic medicine.
By gathering perspectives from both patients and practitioners across geographically diverse regions, the study provides a comprehensive view of current market trends and future expectations.
The consistency of responses across different countries suggests that many of the factors influencing treatment decisions—such as durability, natural outcomes, clinical evidence, and convenience—are becoming universal priorities within aesthetic medicine.
Supporting Galderma’s Vision for Dermatology Leadership
The survey findings arrive as Galderma continues to strengthen its position across the dermatology and aesthetic medicine sectors.
The company has established a broad portfolio spanning Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology, positioning itself to address a wide range of patient needs.
Within the injectable aesthetics market, Galderma continues to invest heavily in research, development, manufacturing, and commercialization capabilities. The company maintains one of the industry’s largest aesthetic innovation pipelines, with numerous active development programs focused on advancing next-generation treatment options.
By combining scientific research with direct insights from healthcare professionals and patients, Galderma aims to guide future product innovation and help shape the evolution of aesthetic medicine.
As global demand for anti-wrinkle treatments continues to expand, the survey reinforces several key themes driving the market: the importance of long-lasting results, the desire for natural-looking outcomes, the value of robust clinical evidence, and the growing expectation for convenient, high-performance solutions.
These insights position Galderma to continue advancing innovation in aesthetic dermatology while supporting practitioners and patients seeking effective, reliable, and personalized treatment experiences.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story.
